Difference between revisions of "June 27 - Clinical-Maturity and others"

Revision as of 22:28, 27 June 2017

Attendees:

Meeting Notes:
- Discussions on email from Lloyd McKenzie on:

~ The criteria are comprehesnive. But will be difficult to fit the clinical maturity criteria into the set of conformance and QA criteria

- Discussions on two different approaches:

~ Option 1: Continue to work on clinical maturity spreadsheet.

~ Then work out way(s) to fit the maturity criteria into

* Risk: unlikely that a fit is possible

~ Or use the maturity criteria as a separate assessment in addition to the existing FHIR maturity levels (Level 0 to 6)

* Risk: implementer resistance. There are expressions on preference to have only one set of maturity assessment criteria

~ Option 2: Formalise a set of robust and useful clinical use cases, and use them to test FHIR resources

@@ Line 16: / Line 16: @@
 <br>
 - Discussions on email from Lloyd McKenzie on:
-:  [http://wiki.hl7.org/index.php?title=FHIR_Conformance_QA_Criteria QA Criteria for FHIR artifacts and IGs]
+: ~ [http://wiki.hl7.org/index.php?title=FHIR_Conformance_QA_Criteria QA Criteria for FHIR artifacts and IGs]
+: ~ The criteria are comprehesnive. But will be difficult to fit the clinical maturity criteria into the set of conformance and QA criteria
 <br>
+- Discussions on two different approaches:
+: ~ Option 1: Continue to work on clinical maturity spreadsheet.
+: ~ Then work out way(s) to fit the maturity criteria into
+:: * Risk: unlikely that a fit is possible
+: ~ Or use the maturity criteria as a separate assessment in addition to the existing [http://wiki.hl7.org/index.php?title=FHIR_Maturity_Model FHIR maturity levels] (Level 0 to 6)
+:: * Risk: implementer resistance. There are expressions on preference to have only one set of maturity assessment criteria
+: ~ Option 2: Formalise a set of robust and useful clinical use cases, and use them to test FHIR resources
 <br>